Vitamin D status may effect the skeletal complications of multiple myeloma

American Journal of Hematology

Volumn 85, Issue 4, 2010, Pages 302-303

  Diamond, Terry ^a   Golombick, Terry ^a   Manoharan, Arumugam ^b  

^a ST GEORGE HOSPITAL   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYPYRIDINOLINE; PARAPROTEIN; SERUM ALBUMIN;

AGED; ALBUMIN BLOOD LEVEL; BONE DENSITOMETRY; BONE DENSITY; BONE DISEASE; BONE RADIOGRAPHY; BONE TURNOVER; CHEMOLUMINESCENCE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HUMAN; LETTER; MALE; MULTIPLE MYELOMA; OSTEOLYSIS; PRIORITY JOURNAL; VITAMIN D DEFICIENCY;

AGED; AGED, 80 AND OVER; BONE DENSITY; BONE DISEASES; CALCIFEDIOL; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NUTRITIONAL STATUS; PREVALENCE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77950395158     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21619     Document Type: Letter

References (4)

1. Badros A, Goloubeva O, Terpos E, et al. Prevalence and significance of vitamin D deficiency in multiple myeloma patients. Br J Haematol 2008;142:492-494.
2. Ng AC, Kumar SK, Rajkumar SV, Drake MT. Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma. Am J Haematol 2009;84:397-400.
3. Diamond T, Mason RS. Understanding the importance of vitamin D for bone and systemic health. Med Today 2009;10:18-25.
4. Dobnig H, Pilz S, Sharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-1349.